Hyperhomocysteinaemia and vascular disease

Area of Science:

• Biochemistry
• Vascular Biology
• Nutritional Science

Background:

• Homocysteine is a critical amino acid in cellular metabolism, involved in methionine remethylation and transsulfuration pathways.
• Hereditary enzyme defects and vitamin cofactor deficiencies can lead to hyperhomocysteinemia, a condition linked to vascular thrombosis.
• Mild hyperhomocysteinemia is recognized as an independent risk factor for arterial and venous thrombosis, though its causes are not fully understood.

Purpose of the Study:

• To explore the role of homocysteine in cell metabolism and its association with vascular disease.
• To investigate potential causes of elevated plasma homocysteine, including genetic factors like methylenetetrahydrofolate reductase variants.
• To examine the in vitro effects of homocysteine on vascular endothelium, platelets, and coagulation.

Main Methods:

• Review of existing literature on homocysteine metabolism and its link to vascular pathologies.
• Analysis of epidemiological evidence associating hyperhomocysteinemia with arterial and venous thrombosis.
• Examination of in vitro studies detailing homocysteine's effects on vascular components.

Main Results:

• A strong association exists between high homocysteine levels and premature vascular thrombosis in hereditary homocystinuria.
• Epidemiological data suggest mild hyperhomocysteinemia is an independent risk factor for vascular disease.
• Conflicting evidence surrounds the causative role of methylenetetrahydrofolate reductase variants in elevated homocysteine.
• In vitro studies indicate homocysteine can negatively impact vascular endothelium, platelets, and coagulation.

Conclusions:

• Dietary folate supplementation can normalize homocysteine levels in affected individuals.
• Folate supplementation may offer a strategy to mitigate the risk of vascular disease associated with hyperhomocysteinemia.